Replies to post #214 on Vanda Pharmaceuticals, Inc. (VNDA)

[surf1944]

8. Vanda Pharmaceuticals, Inc. (VNDA): Biotechnology Industry. Market cap of $164.95M. Net institutional shares sold over the current quarter at 926.5K, which is 3.53% of the company's 26.26M share float. The stock is a short squeeze candidate, with a short float at 5.84% (equivalent to 10.28 days of average volume).

http://seekingalpha.com/article/290509-10-biotech-stocks-being-dumped-by-big-money-managers?source=yahoo